180 related articles for article (PubMed ID: 37936624)
1. Clinical and Genetic Characteristics of Arrhythmogenic Right Ventricular Cardiomyopathy Patients: A Single-Center Experience.
Al-Ghamdi BS; Alhadeq F; Alqahtani A; Alruwaili N; Rababh M; Alghamdi S; Almanea W; Alhassnan Z
Cardiol Res; 2023 Oct; 14(5):379-386. PubMed ID: 37936624
[TBL] [Abstract][Full Text] [Related]
2. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
Al-Ghamdi B; Shafquat A; Mallawi Y
Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
[TBL] [Abstract][Full Text] [Related]
3. Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients.
Al-Ghamdi B; Mallawi Y; Shafquat A; AlRuwaili N; Alhazaymeh A; Al-Manea W; Al-Fayyadh M
Cardiol Res; 2018 Aug; 9(4):204-214. PubMed ID: 30116448
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic variants in plakophilin-2 gene (PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy.
Biernacka EK; Borowiec K; Franaszczyk M; Szperl M; Rampazzo A; Woźniak O; Roszczynko M; Śmigielski W; Lutyńska A; Hoffman P
J Appl Genet; 2021 Dec; 62(4):613-620. PubMed ID: 34191271
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
Agbaedeng TA; Roberts KA; Colley L; Noubiap JJ; Oxborough D
Europace; 2022 Oct; 24(10):1665-1674. PubMed ID: 35298614
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation in arrhythmogenic right ventricular cardiomyopathy-risk of arrhythmias and heart failure.
Christensen AH; Platonov PG; Jensen HK; Chivulescu M; Svensson A; Dahlberg P; Madsen T; Frederiksen TC; Heliö T; Lie ØH; Haugaa KH; Hastrup Svendsen J; Bundgaard H
J Med Genet; 2022 Sep; 59(9):858-864. PubMed ID: 34400560
[TBL] [Abstract][Full Text] [Related]
7. Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria.
Costa S; Medeiros-Domingo A; Gasperetti A; Akdis D; Berger W; James CA; Ruschitzka F; Brunckhorst CB; Duru F; Saguner AM
Circ Genom Precis Med; 2021 Feb; 14(1):e003047. PubMed ID: 33232181
[TBL] [Abstract][Full Text] [Related]
8. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
[TBL] [Abstract][Full Text] [Related]
9. Genetic Variant Score and Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Plakophilin-2 Mutation Carriers.
Svensson A; Platonov PG; Haugaa KH; Zareba W; Jensen HK; Bundgaard H; Gilljam T; Madsen T; Hansen J; Dejgaard LA; Karlsson LO; Gréen A; Polonsky B; Edvardsen T; Svendsen JH; Gunnarsson C
Cardiology; 2021; 146(6):763-771. PubMed ID: 34469894
[TBL] [Abstract][Full Text] [Related]
10. Arrhythmogenic Right Ventricular Cardiomyopathy: A Review of Living and Deceased Probands.
Blusztein DI; Zentner D; Thompson T; Jayadeva P; Liang D; Wang R; Winship I; James PA; Trainer AH; Kalman JM; Vohra J
Heart Lung Circ; 2019 Jul; 28(7):1034-1041. PubMed ID: 30126789
[TBL] [Abstract][Full Text] [Related]
11. Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience.
Scheel PJ; Giuliano K; Tichnell C; James C; Murray B; Tandri H; Carter D; Fehr T; Umapathi P; Vaishnav J; Lewsey SC; Hsu S; Calkins H; Sharma K; Choi CW; Gilotra NA; Kilic A
ESC Heart Fail; 2022 Apr; 9(2):1008-1017. PubMed ID: 34953065
[TBL] [Abstract][Full Text] [Related]
12. Arrhythmogenic right-ventricular cardiomyopathy with plakophilin-2 genetic variant concomitant with early manifestation of ventricular tachyarrhythmia: a case series.
Kawano K; Kondo H; Takahashi M; Shinohara T; Ohno S; Horie M; Takahashi N
Eur Heart J Case Rep; 2022 Oct; 6(10):ytac397. PubMed ID: 36225810
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
Yin K; Ding L; Li Y; Hua W
Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy.
Roudijk RW; Verheul L; Bosman LP; Bourfiss M; Breur JMPJ; Slieker MG; Blank AC; Dooijes D; van der Heijden JF; van den Heuvel F; Clur SA; Udink Ten Cate FEA; van den Berg MP; Wilde AAM; Asselbergs FW; Peter van Tintelen J; Te Riele ASJM
JACC Clin Electrophysiol; 2022 Mar; 8(3):306-318. PubMed ID: 35331425
[TBL] [Abstract][Full Text] [Related]
15. Compound and digenic heterozygosity in desmosome genes as a cause of arrhythmogenic right ventricular cardiomyopathy in Japanese patients.
Nakajima T; Kaneko Y; Irie T; Takahashi R; Kato T; Iijima T; Iso T; Kurabayashi M
Circ J; 2012; 76(3):737-43. PubMed ID: 22214898
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC).
Aljehani A; Kew T; Baig S; Cox H; Sommerfeld LC; Ensam B; Kalla M; Steeds RP; Fabritz L
BMC Cardiovasc Disord; 2023 Jan; 23(1):14. PubMed ID: 36635648
[TBL] [Abstract][Full Text] [Related]
17. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.
van Tintelen JP; Entius MM; Bhuiyan ZA; Jongbloed R; Wiesfeld AC; Wilde AA; van der Smagt J; Boven LG; Mannens MM; van Langen IM; Hofstra RM; Otterspoor LC; Doevendans PA; Rodriguez LM; van Gelder IC; Hauer RN
Circulation; 2006 Apr; 113(13):1650-8. PubMed ID: 16567567
[TBL] [Abstract][Full Text] [Related]
18. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy.
Xu T; Yang Z; Vatta M; Rampazzo A; Beffagna G; Pilichou K; Scherer SE; Saffitz J; Kravitz J; Zareba W; Danieli GA; Lorenzon A; Nava A; Bauce B; Thiene G; Basso C; Calkins H; Gear K; Marcus F; Towbin JA;
J Am Coll Cardiol; 2010 Feb; 55(6):587-97. PubMed ID: 20152563
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
[TBL] [Abstract][Full Text] [Related]
20. Correlation of ventricular arrhythmias with genotype in arrhythmogenic right ventricular cardiomyopathy.
Bao J; Wang J; Yao Y; Wang Y; Fan X; Sun K; He DS; Marcus FI; Zhang S; Hui R; Song L
Circ Cardiovasc Genet; 2013 Dec; 6(6):552-6. PubMed ID: 24125834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
